A bacterial flavin reductase system reduces chromate to a soluble chromium(III)–NAD + complex

Biological reduction of carcinogenic chromate has been extensively studied in eukaryotic cells partly because the reduction produces stable chromium(III)-DNA adducts, which are mutagenic. Microbial reduction of chromate has been studied for bioremediation purposes, but little is known about the redu...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 294; no. 1; pp. 76 - 81
Main Authors Puzon, Geoffrey J., Petersen, James N., Roberts, Arthur G., Kramer, David M., Xun, Luying
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 31.05.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biological reduction of carcinogenic chromate has been extensively studied in eukaryotic cells partly because the reduction produces stable chromium(III)-DNA adducts, which are mutagenic. Microbial reduction of chromate has been studied for bioremediation purposes, but little is known about the reduction mechanism. In eukaryotic cells chromate is mainly reduced non-enzymatically by ascorbate, which is usually absent in bacterial cells. We have characterized the reduction of chromate by a flavin reductase (Fre) from Escherichia coli with flavins. The Fre-flavin system rapidly reduced chromate, whereas chemical reduction by NADH and glutathione was very slow. Thus, enzymatic chromate reduction is likely the dominant mechanism in bacterial cells. Furthermore, the end-product was a soluble and stable Cr(III)–NAD + complex, instead of Cr(III) precipitate. Since intracellularly generated Cr(III) forms adducts with DNA, protein, glutathione, and ascorbate in eukaryotic cells, we suggest that the produced Cr(III) is primarily complexed to NAD +, DNA, and other cellular components inside bacteria.
ISSN:0006-291X
1090-2104
DOI:10.1016/S0006-291X(02)00438-2